Literature DB >> 2105953

Inhibition of IgA1 proteinases from Neisseria gonorrhoeae and Hemophilus influenzae by peptide prolyl boronic acids.

W W Bachovchin1, A G Plaut, G R Flentke, M Lynch, C A Kettner.   

Abstract

The alpha-aminoboronic acid analog of proline has been synthesized and incorporated into a number of peptides as the COOH-terminal residue. These peptide prolyl boronic acids are potent inhibitors of both the type 1 and type 2 IgA proteinases from Neisseria gonorrhoeae and Hemophilus influenzae, but not of the functionally similar IgA proteinase from Streptococcus sanguis. The best inhibitors synthesized thus far have Ki values in the nanomolar range (4.0 to 60 nM). These results indicate that the N. gonorrhoeae and the H. influenzae enzymes belong to the serine protease family of proteolytic enzymes while that from S. sanguis does not. As a group, the IgA proteinases have been noted for their remarkable specificity; thus, the peptide prolyl boronic acids reported here are the first small synthetic molecules to exhibit a relatively high affinity for the active site of an IgA proteinase and are therefore the first to yield some insight into the active site structure and specificity requirements of these enzymes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105953

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation.

Authors:  K Al-Hasani; I R Henderson; H Sakellaris; K Rajakumar; T Grant; J P Nataro; R Robins-Browne; B Adler
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases.

Authors:  B W Senior; J I Dunlop; M R Batten; M Kilian; J M Woof
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 3.  Type V protein secretion pathway: the autotransporter story.

Authors:  Ian R Henderson; Fernando Navarro-Garcia; Mickaël Desvaux; Rachel C Fernandez; Dlawer Ala'Aldeen
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

4.  Characterization of the immunoglobulin A protease of Ureaplasma urealyticum.

Authors:  R K Spooner; W C Russell; D Thirkell
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

5.  Development of a high-throughput screen and its use in the discovery of Streptococcus pneumoniae immunoglobulin A1 protease inhibitors.

Authors:  Amanda L Garner; Jessica L Fullagar; Joshua A Day; Seth M Cohen; Kim D Janda
Journal:  J Am Chem Soc       Date:  2013-06-28       Impact factor: 15.419

6.  Antigenic relationships among immunoglobulin A1 proteases from Haemophilus, Neisseria, and Streptococcus species.

Authors:  H Lomholt; M Kilian
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Inhibition of dipeptidyl peptidase IV by fluoroolefin-containing N-peptidyl-O-hydroxylamine peptidomimetics.

Authors:  J Lin; P J Toscano; J T Welch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  Functional analysis of the Tsh autotransporter from an avian pathogenic Escherichia coli strain.

Authors:  Maria Kostakioti; Christos Stathopoulos
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Molecular polymorphism and epidemiology of Neisseria meningitidis immunoglobulin A1 proteases.

Authors:  H Lomholt; K Poulsen; D A Caugant; M Kilian
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

10.  The expression of soluble and active recombinant Haemophilus influenzae IgA1 protease in E. coli.

Authors:  Shinong Long; Elaine Phan; Michel C Vellard
Journal:  J Biomed Biotechnol       Date:  2010-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.